The announcement follows the ministry of health’s plan of loosening restrictions around medical cannabis. In August 2018, for the treatment of chronic pain, cancer, neuro-degenerative and other chronic diseases.

Meanwhile, the recreational use of cannabis is still restricted but has seen some recent changes. On 22 October, the government each household could cultivate up to 4 cannabis plants for personal use, though public consumption of the drug remains prohibited.

In an official statement, Tilray, which now supplies 20 countries around the world, announced that it “will supply a variety of its pharmaceutical-grade medical cannabis products, including extracts and dried flower with different degrees of THC and CBD for patients with varying medical conditions. These prescription-based medical cannabis products will be administered to qualifying patients in Luxembourg under the supervision of physicians.”